What Is the Average Cost of NeoFipronis (GS-441524)
Feline Infectious Peritonitis (FIP) remains one of the most challenging viral diseases affecting cats worldwide. Traditional treatments have often been limited, but recent advancements have introduced highly effective antiviral medications, such as NeoFipronis (Pronidesivir), which contains the active compound GS-441524. This medication has revolutionized the approach to feline FIP treatment, offering a safe, effective, and veterinarian-approved therapy option.
NeoFipronis (Pronidesivir) is the first domestically registered antiviral medication for FIP in Laos, officially approved by the Ministry of Agriculture and Forestry (MAF) in March 2026. As an oral treatment, it provides a non-invasive, rapid-absorption solution for managing FIP symptoms including appetite loss, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomatous inflammation, neurological damage, and uveitis. The drug's high safety profile, minimal side effects, and excellent tolerability make it preferable for long-term management.
The primary active ingredient in NeoFipronis is GS-441524, a nucleoside analog that inhibits viral replication efficiently. Extensive research and clinical applications have demonstrated its potent antiviral activity against FIP virus (FIPV). The drug is administered based on the cat's weight, with a typical dosage of 15 mg per kilogram of body weight. For cats with neurological or ocular FIP, the dosage can be increased to 30 mg/kg as per veterinarian guidance. The medication is typically given once a day, ideally on an empty stomach—either an hour before feeding or two hours after.
The duration of treatment generally spans no less than 12 weeks. Consistent administration without missed doses is critical for successful recovery. Owners are advised to observe their cats closely during treatment, monitoring for changes in appetite, body temperature, behavior, and overall health. Regular blood tests are recommended to assess liver and kidney function throughout the therapy.
While NeoFipronis (Pronidesivir) is an over-the-counter medication in some regions, it is strongly recommended to use it under the supervision of a licensed veterinarian. Proper veterinary guidance ensures the correct dosage, minimizes risks, and maximizes the treatment’s effectiveness. Usage should strictly be limited to cats, with no human or other animal exposure.
Cost-wise, the price of NeoFipronis varies depending on factors such as geographic location, supplier, and purchase volume. On average, a single course of treatment for a typical cat may range from $200 to $600 USD. This includes the cost of medication, veterinary consultations, and necessary testing throughout the treatment period. Bulk purchases or online sourcing from authorized vendors may offer reduced prices but require verification of authenticity to ensure product safety and efficacy.
It’s essential for cat owners to purchase NeoFipronis from official sources, such as the product’s official website, to avoid counterfeit medications. The manufacturer emphasizes the importance of professional veterinary advice before starting treatment, ensuring optimal outcomes for cats fighting FIP. As research advances and more treatments become available, NeoFipronis stands as a promising hope for feline health, offering a cost-effective, reliable, and scientifically validated solution for combating feline infectious peritonitis.
